10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepin-3-carboxylic acid → HCID 13013940, Verbindung
Reaktionsgleichung
[O:1]=[C:2]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[S:6][C:5]2[CH:13]=[C:14]([C:17]([OH:19])=[O:18])[CH:15]=[CH:16][C:4]=2[NH:3]1.O=[C:21]1C2C=CC(C(O)=O)=CC=2SC2C=CC=CC=2N1>>[O:1]=[C:2]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[S:6][C:5]2[CH:13]=[C:14]([C:17]([O:19][CH3:21])=[O:18])[CH:15]=[CH:16][C:4]=2[NH:3]1Komponenten
3
Versuchsvorschrift
Repeat the process of Example 31, substituting 10,11-dihydro-11-oxodibenzo[b,f][1,4]thiazepin-7-carboxylic acid for the 10,11-dihydro-11-oxodibenzo[b,f][1,4]thiazepin-3-carboxylic acid of Step A, in order to obtain the title product.
Quellen und Nachweise
- ORD-Eintrag
- ord-efc2236fbf174213993b8eddacfe8544
- Quelldatensatz
- uspto-grants-1981_04
- Patentnummer
- US04263207